The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies
Titel:
The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies
Auteur:
Moretto, R. Rossini, D. Polito, Mariam Grazia Antoniotti, Carlotta Intini, Rossana Conca, Veronica Andena, Paola Carullo, Martina Salvatore, Lisa Germani, Marco Maria Bergamo, Francesca Passardi, Alessandro Ciracì, Paolo Tamburini, Emiliano Boccaccio, Chiara Zaniboni, Alberto Masi, Gianluca Pietrantonio, Filippo Lonardi, Sara Cremolini, C.